Last reviewed: August 30, 2026. Educational content for adults 21+. This is not medical or legal advice. Kiody does not sell concentrated 7-OH products.
Suggested page: Learning Center → Responsible Use & Product Literacy
Secondary topics: kratom label requirements, kratom serving size, kratom lot number, 7-OH label, kratom COA QR code
Important context before reading any label
This guide is educational and intended for adults 21+. It is not medical or legal advice. Kiody does not sell concentrated 7-hydroxymitragynine (7-OH), mitragynine pseudoindoxyl, MGM-15, or MGM-16.
A detailed label can help a reader understand what a company says is inside a package and connect it to a particular lot. It cannot prove that the product is safe, effective, FDA-approved, correctly manufactured, accurately tested, or legal in every jurisdiction.
FDA currently states that kratom is not lawfully marketed in the United States as a dietary supplement, an approved drug, or an additive in conventional food. State laws may separately regulate, restrict, or prohibit botanical kratom and concentrated or synthetic products. This guide uses federal food- and dietary-supplement labeling rules as authoritative examples of label structure and quality-system principles, not as a claim that placing those elements on a kratom package resolves FDA’s federal position. FDA and Kratom
A label is a map, not a guarantee
The best way to read a kratom label is to treat it as a map of claims that need to connect:
- the front panel should identify the product and quantity;
- the information panel should explain ingredients, servings, warnings, and the responsible business;
- the lot number should connect the package to manufacturing and testing records;
- a QR code should lead to the exact lot’s supporting information rather than a generic homepage;
- alkaloid statements should use defined units that make mathematical sense; and
- every online product page should agree with the physical package.
When those pieces conflict, the consumer should not guess which one is correct. A bottle that says “60 capsules,” a web page that says “90 count,” and a COA describing bulk powder are three different records. They may all look professional while failing to describe the same product.
The label’s job is not merely to look compliant. It should allow a reasonable adult to identify the product, understand the package and serving units, find the lot record, recognize important restrictions, and contact the responsible company.
Step 1: Identify the product form
Start with the simplest question: what is this?
Kratom is sold in forms that can look similar online while having very different composition and legal treatment:
- whole or cut botanical leaf;
- botanical leaf powder;
- pure-leaf capsules;
- dry extract powder;
- liquid extract or tincture;
- beverage or drink mix;
- gummies, tablets, or pressed products;
- products enhanced with isolated alkaloids;
- concentrated 7-OH products; and
- synthesized or semi-synthesized derivatives.
“Kratom” alone is not enough. “Green Maeng Da” or “Red Bali” is a commercial variety name, not a complete product-form description. A careful label should make clear whether the package contains ordinary ground leaf, pure-leaf capsules, an extract, or another formulation.
This distinction matters because extract concentration cannot be inferred from color or strain language. A capsule can contain pure botanical leaf, extract, or a blend. A small tablet may contain a highly concentrated ingredient. A liquid may be a ready-to-use beverage or a concentrated product intended to be divided into servings.
For Kiody, pure-leaf capsules should be described consistently as pure botanical leaf, approximately 500 milligrams of leaf powder per capsule. The word “approximately” should not become an excuse for uncontrolled fill variation; it should match the product specification, weight-control records, and final label review.
Step 2: Look for an honest identity statement
An identity statement tells the reader what the product is in ordinary language. Under the federal food-labeling framework, 21 CFR §101.3 addresses identity labeling for packaged food. FDA’s Food Labeling Guide also treats the statement of identity as a core label element. 21 CFR §101.3, FDA Food Labeling Guide
For product literacy, a useful kratom identity statement might distinguish:
- “Mitragyna speciosa leaf powder” from “kratom extract”;
- loose powder from capsules;
- a single botanical from a multi-ingredient blend; and
- natural leaf from products with added or enhanced alkaloids.
The botanical name can improve specificity, but it should not replace plain language. When a botanical is named under the dietary-supplement labeling framework, 21 CFR §101.36 calls for identifying the plant part. That makes “Mitragyna speciosa leaf” more informative than a botanical name without the part. 21 CFR §101.36
Identity red flags
- “Advanced botanical” without saying whether it is leaf or extract.
- “Kratom alkaloids” without naming the source or product form.
- A capsule listing that omits whether the contents are pure leaf or extract.
- A 7-OH product styled to look like ordinary leaf.
- “Natural” used as a substitute for a full identity statement.
- “Proprietary technology” used to obscure concentrated or semi-synthetic ingredients.
Step 3: Separate commercial color names from composition
Red, green, and white are common commercial categories. Names such as Bali, Maeng Da, Malay, Hulu, Vietnam, and Ketapang are also widely used in retail catalogs. They can help organize a product line, but the name alone does not prove geographic origin, chemistry, purity, potency, or a predictable experience.
A label should not transform a commercial name into an unsupported medical or performance promise. “Green” does not prove stimulation. “Red” does not prove sedation. “White” does not prove focus. Batch composition can vary, and consumer response is not established by package color.
Useful label and product-page language can say what is objectively known:
- the commercial variety name;
- product form;
- net weight or count;
- ingredient identity;
- lot number;
- tested characteristics; and
- directions and warnings approved for the product.
Descriptions such as “cures anxiety,” “treats pain,” “replaces opioids,” or “safe alternative to medication” are not acceptable educational shortcuts. FDA has repeatedly acted against unapproved drug claims involving kratom and 7-OH products. FDA 7-OH warning-letter announcement
Step 4: Check net quantity separately from serving size
Net quantity answers how much product the package contains. Serving size answers how much the label treats as one serving. They are not interchangeable.
Under the federal food-labeling framework, 21 CFR §101.7 requires packaged foods to declare net quantity by weight, measure, count, or an appropriate combination. The declaration must accurately describe the contents, excluding wrappers and packing material. 21 CFR §101.7
Examples of net-quantity statements include:
- Net Wt. 100 g;
- 60 capsules;
- 60 capsules / Net Wt. 30 g;
- Net 15 mL; or
- 10 single-use packets, 5 g each.
A package can contain 100 grams but recommend a much smaller serving. A 60-count capsule bottle can use two capsules as a serving, giving 30 labeled servings. A liquid bottle can contain 15 milliliters but define multiple servings. The reader should never have to reverse-engineer whether the front-panel number means package quantity, ingredient amount, or amount per serving.
A pure-leaf capsule example
Suppose a bottle contains 120 pure-leaf capsules with approximately 500 mg of leaf powder per capsule.
- One capsule: approximately 500 mg leaf powder.
- Two-capsule serving: approximately 1,000 mg, or 1 gram, of leaf powder.
- 120 capsules: approximately 60,000 mg, or 60 grams, of leaf powder in total.
- If serving size is two capsules: 60 servings per container.
Those calculations are useful checks, but the label and production records remain authoritative for the actual product. The shell, excipients, and permissible manufacturing variation must be handled correctly by the responsible business. A buyer should not assume that multiplying a marketing estimate always equals the regulated net quantity.
Step 5: Read the ingredient list literally
Ingredient lists should tell the reader what materials were used, not merely repeat a brand name.
Under 21 CFR §101.4, food ingredients generally are identified by common or usual name in descending order of predominance by weight, subject to applicable exceptions. 21 CFR §101.4
For kratom product literacy, ask:
- Is the plant identified?
- Is the plant part identified as leaf?
- Does a capsule disclose the capsule material?
- Are flavors, sweeteners, acids, carriers, preservatives, colors, and other ingredients disclosed?
- Is an extract described as an extract rather than ordinary leaf?
- Are added alkaloids named?
- Does the ingredient list match the online description and COA matrix?
“Proprietary blend” should not conceal the presence of 7-OH, mitragynine pseudoindoxyl, MGM-15, MGM-16, or another material with distinct legal consequences. A “botanical blend” label does not turn a scheduled or synthesized compound into ordinary leaf.
Pure leaf versus extract
If a product contains only ground leaf in a capsule, the ingredient statement should not imply that it is an extract. If it contains extract, the front and information panels should not present it as simple leaf powder.
This is more than an ingredient-list issue. Serving math, alkaloid concentration, consumer expectations, test methods, and legal thresholds can all change with product form.
Step 6: Find the responsible business
A useful label identifies the manufacturer, packer, or distributor and provides a physical address or another legally adequate place-of-business statement. Under the general federal food-labeling framework, 21 CFR §101.5 addresses the name and place of business of the responsible entity. 21 CFR §101.5
Consumers also benefit from a working phone number, email address, or product-quality contact route. That contact should allow the customer to report:
- the exact product;
- lot number;
- purchase location and date;
- package condition;
- missing or incorrect contents;
- unexpected odor, color, moisture, or foreign material;
- adverse event or safety concern; and
- photographs or retained product when appropriate.
A social-media handle alone is not robust traceability. A marketplace seller name with no responsible business information makes complaints and recalls harder.
Step 7: Locate the lot, batch, or control number
The lot number may be the most valuable small piece of text on the package.
Under 21 CFR §111.3, a batch, lot, or control number is a distinctive set of letters, numbers, symbols, or a combination that allows the complete manufacturing, packaging, labeling, and holding history to be determined. Part 111 also requires assigning such identifiers to lots of packaged and labeled dietary supplements within that framework. 21 CFR §111.3, 21 CFR §111.415
Again, Part 111 does not establish that kratom is lawfully marketed as a federal dietary supplement. It provides a strong definition of what a meaningful lot number should accomplish.
A useful lot number should connect to
- incoming botanical or ingredient lots;
- manufacturing or blending records;
- capsule-filling or packaging run;
- equipment and cleaning records;
- label version;
- finished-product testing;
- release decision;
- reserve sample;
- distribution history; and
- complaints, returns, or recalls.
Lot-number red flags
- No lot number appears.
- The number rubs off or is hidden under a seam.
- Every product links to the same generic COA regardless of lot.
- The package lot and COA lot differ by unexplained characters.
- A new package carries an older product’s test report.
- The code is only a “best by” date with no traceable lot relationship.
- A sticker covers the original lot number.
Step 8: Treat dates carefully
A manufacture date, packaging date, testing date, release date, “best by” date, and expiration date describe different events.
An old testing date is not automatically wrong if it belongs to a long-held lot, but the relationship should be explainable. A COA dated before the product was manufactured may describe an input rather than the finished product. A label printed months after a COA may be legitimate, but the lot match must remain clear.
FDA’s dietary-supplement CGMP guidance explains that the federal Part 111 rule does not itself require an expiration or shelf-life date; when a company uses one, it should have data supporting it. FDA Small Entity Compliance Guide
A date should not be invented because consumers expect to see one. Storage studies, packaging, moisture control, microbiological risk, chemical stability, and real distribution conditions should support the company’s dating approach.
Step 9: Understand serving size and servings per container
Serving size is central to every per-serving statement. It should name an actual amount a consumer can measure:
- grams of powder;
- number of capsules;
- milliliters of liquid;
- number or fraction of a tablet; or
- one premeasured packet.
Avoid labels that define a serving as “one scoop” without identifying scoop capacity and corresponding mass. Powder density can change, and a heaping scoop is not the same as a level scoop. A gram value is easier to audit than a vague utensil description.
For liquids, “one dropper” can be ambiguous because droppers may not fill completely and may have no calibration. A milliliter value and calibrated delivery device provide clearer information.
Serving math checklist
- Identify the mass, volume, or unit count in one serving.
- Identify the total net quantity or count.
- Divide total usable quantity by serving quantity.
- Compare the result with “servings per container.”
- Allow for legitimate package and measurement conventions, but investigate material conflicts.
If a 30-gram package declares a 2-gram serving, it should contain about 15 servings. If the label says 30 servings, one of the numbers needs explanation.
Step 10: Decode alkaloid units before comparing products
The number is meaningless without its unit and basis.
Kratom labels and COAs may express alkaloids as:
- percent by weight;
- milligrams per gram (mg/g);
- milligrams per milliliter (mg/mL);
- milligrams per capsule;
- milligrams per serving;
- milligrams in the entire package;
- percentage of total alkaloid composition; or
- a ratio such as mitragynine to 7-OH.
These measures are not interchangeable without the required inputs.
Percent by weight and mg/g
For a weight-to-weight percentage:
- 1% equals 10 mg/g.
- 0.1% equals 1 mg/g.
- 0.05% equals 0.5 mg/g.
- 0.01% equals 0.1 mg/g.
The calculation is:
percent × 10 = mg/g
To reverse it:
mg/g ÷ 10 = percent
But the basis still matters. A dry-weight percentage can differ from an as-received result when moisture is present.
From mg/g to mg per serving
Multiply concentration by serving mass:
mg/g × serving grams = mg per serving
Example: a powder reported at 0.2 mg/g 7-OH with a 2-gram serving contains a calculated 0.4 mg 7-OH per serving.
That calculation assumes the result represents the finished product and that the serving mass is correct. It does not establish legal compliance in every jurisdiction.
Percent of total alkaloids
A rule limiting 7-OH to a percentage of total alkaloid composition uses a different denominator from percent of total product weight.
Example:
- total measured alkaloids: 15 mg/g;
- measured 7-OH: 0.3 mg/g;
- 7-OH fraction: 0.3 ÷ 15 × 100 = 2% of total alkaloids.
The product itself is not 2% 7-OH. In this example, 0.3 mg/g equals 0.03% of total product weight, assuming a weight-to-weight basis. Confusing these two percentages can create a 60-fold misunderstanding.
Per package versus per serving
A label that reports 0.5 mg per serving and 20 servings per package implies 10 mg in the package if every serving is uniform:
0.5 mg × 20 = 10 mg total
If the label’s total does not match the per-serving statement, the business should explain rounding or correct the conflict.
Step 11: Match the label to the COA
A QR code is useful only when it resolves to relevant, readable evidence.
The lot-specific record should agree with the package on:
- product name;
- product form;
- lot or batch number;
- manufacturer or client identity when disclosed;
- sample matrix;
- sampling date when available;
- laboratory receipt and testing dates;
- analytes;
- actual results and units; and
- report status and authorized signature.
If the label says pure-leaf capsules but the COA describes “extract powder,” stop. If the bottle lot is K240801 and the linked report is K230315, stop. If the label states alkaloids per serving but the COA only reports percent by weight, verify the conversion and serving mass.
A QR code should not
- lead only to the store homepage;
- require creating a marketing account;
- display a generic “passed” badge;
- show a report with a different lot;
- hide actual results;
- redirect to an editable document with no revision history; or
- collect unnecessary personal information before showing the report.
The most useful QR destination can display the COA, explain units in plain language, identify the testing scope, and provide a contact route for questions.
Step 12: Read “tested” claims narrowly
“Lab tested” does not mean “tested for everything.”
A product might be tested for:
- botanical identity;
- mitragynine and 7-OH;
- other named alkaloids;
- Salmonella;
- pathogenic or generic E. coli;
- aerobic plate count;
- yeast and mold;
- lead, arsenic, cadmium, mercury, or other elements;
- a defined pesticide panel;
- named mycotoxins;
- residual solvents;
- moisture content; or
- water activity.
Each category uses different methods and answers different questions. A microbial panel does not verify alkaloid content. An alkaloid assay does not identify heavy metals. A metal panel does not prove botanical identity.
The label and website should avoid an unlimited claim such as “100% safe and pure.” No finite test panel establishes that every hazard is absent. Better language identifies the lot and the specific tests performed.
Step 13: Evaluate warning language
Warnings should be visible, specific, internally consistent, and appropriate to the product and jurisdiction. A microscopic disclaimer on the bottom of a package does not balance a large medical promise on the front.
For Kiody, the baseline positioning should remain:
- adults 21+ only;
- keep away from children;
- not medical advice;
- no promise to diagnose, treat, cure, or prevent disease;
- consult a qualified health professional about individual circumstances, medicines, pregnancy, nursing, or health conditions;
- follow current jurisdiction-specific rules; and
- Kiody does not sell concentrated 7-OH.
Warning language should not imply that a product is FDA-approved or that consulting a physician turns an unlawful or unsuitable product into an approved one.
FDA advises consumers not to use kratom and warns about serious adverse events. FDA also specifically recommends avoiding products containing added or enhanced 7-OH. Kiody’s educational content should state FDA’s position accurately without turning the warning into sensational copy or making contrary medical promises. FDA and Kratom, FDA consumer information on 7-OH
Step 14: Check age language on both the package and product page
Kiody is 21+ even where a jurisdiction may set a lower minimum age. The site, label, checkout, marketing, and delivery controls should not contradict that policy.
Age language can also be jurisdiction-specific. New York Public Health Law §1399-xx, effective statewide in 2026, requires a prescribed warning statement on physical and online places where kratom is offered for sale. On websites and mobile applications, the statutory statement must appear in red lettering in at least 12-point font on product-offer pages or screens. New York also prohibits knowing sale to people under 21. New York Public Health Law §1399-xx
This illustrates a common mistake: placing an age notice only in a website footer may not satisfy a rule requiring it on every page where the product is offered.
Step 15: Treat state label rules as product-routing rules
There is no responsible “one label fits all states forever” assumption.
Georgia’s H.B. 181, effective January 1, 2025, provides a detailed example. Kratom sold in or delivered to Georgia must be naturally derived and satisfy specific mitragynine and 7-OH limits. Its label provisions include ingredient information, a 21+ notice, amounts of mitragynine and 7-OH in the product and package, responsible-business information, serving directions, precautionary statements, and restrictions on therapeutic claims. Georgia H.B. 181, Act 546
Georgia’s numerical limits are simultaneous:
- no more than 150 mg mitragynine per serving;
- no more than 0.5 mg 7-OH per gram; and
- no more than 1 mg 7-OH per serving.
A label showing only one of those values may not provide enough information to review the others. A product with a compliant concentration can still exceed a per-serving limit if the serving is large.
Other states use different formulas, ages, warnings, licensing requirements, or product prohibitions. Some prohibit all botanical kratom. Some regulate natural leaf while prohibiting concentrated or synthetic forms. Some apply to products delivered into the state, which makes online product data part of shipping compliance.
Labels therefore should connect to a current jurisdiction review rather than serve as the review themselves.
Step 16: Recognize claim language that changes the regulatory picture
Product claims appear on more than the physical package. FDA can evaluate websites, social posts, testimonials adopted by a seller, brochures, marketplace listings, emails, and other labeling or promotional materials.
Claims such as these raise serious concerns:
- treats pain;
- cures anxiety;
- prevents withdrawal;
- replaces prescription medication;
- fixes depression;
- safe opioid alternative;
- guaranteed energy;
- clinically proven when no appropriate evidence exists; or
- FDA approved when it is not.
Adding “not intended to diagnose, treat, cure, or prevent disease” does not neutralize explicit disease-treatment claims elsewhere. The overall presentation matters.
Kiody’s product education should focus on identity, form, batch documentation, test interpretation, responsible adult-use information, and legal distinctions without promising an outcome.
Step 17: Understand the current federal 7-OH and derivative status
The federal picture contains two separate actions that labels and education pages should not merge.
The federal 7-OH threshold remains proposed
DEA’s July 6, 2026 notice of intent proposes temporary Schedule I placement for 7-OH above specified thresholds. HHS is accepting threshold-related comments through September 10, 2026 after an August 26 extension. The proposal includes a dry-weight threshold for botanical material and concentration or per-article tests for certain alternative forms.
As of this draft date, the notice and request for information are not the final temporary scheduling order. A product label should not state that the proposed federal threshold is already current federal Schedule I law. DEA 7-OH notice of intent, HHS comment extension
MP, MGM-15, and MGM-16 are already temporarily Schedule I
DEA placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I effective August 26, 2026, through August 26, 2028 unless extended or made permanent through further action. Unauthorized retail sale and possession are prohibited under the Controlled Substances Act. DEA temporary scheduling order
DOJ separately states that it will exercise enforcement discretion when only incidental trace MP is confirmed in a product otherwise consistent with botanical kratom. DOJ expressly says this does not create a legal exemption or change MP’s Schedule I status. The policy does not apply to MGM-15, MGM-16, or manufactured, concentrated, fortified, or intentionally added MP. It provides no numerical “trace” threshold. DOJ August 25, 2026 enforcement statement
A label should never use “trace” as a self-created legal safe harbor.
Twenty kratom label red flags
- The product form is unclear.
- The label calls an extract “plain leaf.”
- Capsules do not disclose whether they contain leaf or extract.
- There is no lot number.
- The COA lot does not match the package.
- The QR code leads to a generic homepage.
- “Lab tested” appears without actual results or scope.
- Serving size is “one scoop” with no mass.
- Servings per container do not match net quantity.
- Alkaloid numbers have no units.
- Percent of total product and percent of total alkaloids are treated as identical.
- Per-serving and total-package statements conflict.
- The label lists 7-OH only as a marketing feature without distinguishing added or enhanced material.
- “Natural” is used to disguise synthesized or semi-synthesized ingredients.
- The responsible business cannot be identified or contacted.
- A disclaimer appears next to explicit disease-treatment promises.
- Age language conflicts across the label, website, and checkout.
- State-specific warnings are missing from pages where the product is offered.
- The product is described as FDA-approved without evidence.
- A scheduled derivative is hidden inside a proprietary blend or euphemism.
Five worked label-reading examples
Example 1: Pure-leaf capsules with clear math
The bottle says 120 pure-leaf capsules, approximately 500 mg leaf powder per capsule, with a serving size of two capsules and 60 servings per container. The lot number matches a finished-capsule COA.
The arithmetic is internally consistent. The next questions concern actual fill controls, testing scope, lot sampling, ingredients in the shell, warnings, responsible-business information, and jurisdiction eligibility. Clear math is a good sign, not proof of every quality claim.
Example 2: A powder with a vague scoop
The pouch says Net Wt. 100 g and serving size “one scoop.” No scoop mass is listed.
The consumer cannot reliably calculate servings or a per-serving alkaloid amount. Density, settling, and whether the scoop is level can change the mass. The label should provide a gram amount and ensure any included scoop is appropriate.
Example 3: A misleading 2% statement
The package says “legal 2% 7-OH,” but does not state whether 2% refers to total product weight or total alkaloid composition.
Those are radically different measures. The claim also assumes a jurisdiction, effective date, product form, and legal formula. “Legal 2%” is not an adequate result or universal compliance statement.
Example 4: A QR code with the wrong matrix
A bottle of pure-leaf capsules links to a COA for bulk kratom extract.
The report does not match the product form. Even if the lot number looks similar, the seller should provide the finished-product record or explain the traceability chain without presenting the extract result as a capsule COA.
Example 5: “Trace MP” as a marketing claim
A label says “federally legal trace pseudo” and provides no result, method, or explanation.
That statement is inaccurate. MP remains Schedule I. DOJ’s current enforcement-discretion policy for only incidental trace MP in a product otherwise consistent with botanical kratom is not a legal exemption and contains no numerical threshold. Intentionally added, manufactured, concentrated, or fortified MP is outside the policy.
A proposed 24-point Kiody label review record
For internal review and adaptation by qualified quality and legal personnel:
- product name;
- product form;
- botanical name and plant part;
- commercial variety name;
- leaf, extract, or blend declaration;
- complete ingredient statement;
- allergen review when applicable;
- net quantity and units;
- capsule, packet, tablet, or unit count;
- serving size;
- servings per container;
- serving-math verification;
- alkaloid declarations and units;
- per-serving and per-package calculation review;
- lot, batch, or control number;
- manufacture, package, best-by, or expiration-date basis;
- responsible-business name and address;
- customer and adverse-event contact route;
- 21+ statement and age-control review;
- warnings and prohibited-claim review;
- state-specific label or offer-page requirements;
- QR destination and exact lot match;
- approved artwork revision and obsolete-label control; and
- final quality and legal approval before release.
The record should identify the reviewer and date. It should preserve the approved artwork rather than only checking a physical package after thousands are printed.
Frequently asked questions
What is the first thing to check on a kratom label?
Confirm the product form. Determine whether it is whole leaf, powder, pure-leaf capsules, extract, liquid, or an enhanced or synthetic product. The rest of the label depends on that identity.
Does “500 mg capsule” mean 500 mg mitragynine?
No. For Kiody’s pure-leaf capsules, approximately 500 mg refers to leaf powder per capsule, not 500 mg of mitragynine. A label should state the basis clearly.
Is net weight the same as serving size?
No. Net weight describes the package contents. Serving size describes the amount assigned to one serving.
Why is the lot number important?
It connects the package to manufacturing, testing, release, distribution, complaint, and recall records. A COA without an exact lot match may describe different material.
Does a QR code prove a product was tested?
No. Open it and verify the product, lot, matrix, dates, laboratory, methods, results, units, and report status.
What does mg/g mean?
Milligrams of the measured substance per gram of product. Multiply mg/g by serving grams to calculate a theoretical milligram amount per serving.
Is 0.05% the same as 0.5 mg/g?
Yes, on the same weight-to-weight basis: 0.05% × 10 = 0.5 mg/g. Moisture or dry-weight adjustments can still affect the applicable basis.
Is 2% of total alkaloids the same as 2% of the product?
No. The denominator is different. A product can contain 7-OH equal to 2% of its measured alkaloid fraction while containing far less than 2% 7-OH by total product weight.
Should a kratom label list the plant part?
Identifying the leaf improves clarity and aligns with the botanical-identification principle reflected in federal dietary-supplement labeling rules. It also helps distinguish leaf from isolated or synthesized compounds.
Does a disclaimer cancel a medical claim?
No. An explicit claim to treat, cure, prevent, or mitigate disease is not neutralized simply by placing a disclaimer elsewhere.
Are color names reliable potency grades?
No. Red, green, and white are commercial categories, not standardized potency certifications. Lot-specific evidence is more informative than package color.
Does a passing COA prove the label is correct?
No. A COA can support some composition and contaminant statements. It does not automatically verify net quantity, serving count, package identity, warnings, claims, age language, or legal eligibility.
Can a raw-material COA represent finished capsules?
It can support source-material review, but it does not examine the later blending, filling, packaging, or labeling steps. The relationship should be disclosed accurately.
Is the proposed federal 7-OH threshold already law?
Not as of August 29, 2026. DEA published a notice of intent, and HHS extended threshold comments through September 10, 2026. A separate order for MP, MGM-15, and MGM-16 is already effective.
Does DOJ’s trace-MP policy make trace MP legal?
No. DOJ expressly says the policy is enforcement discretion, not a legal exemption, and MP remains Schedule I. The policy provides no numerical trace threshold.
Does Kiody sell concentrated 7-OH?
No. Kiody is 21+ and does not sell concentrated 7-OH, mitragynine pseudoindoxyl, MGM-15, or MGM-16.
The practical takeaway
A trustworthy label lets the reader answer five questions without guessing:
- What exactly is the product?
- How much is in the package and one serving?
- Which ingredients and alkaloid units are being declared?
- Which exact lot does the package belong to, and where is its evidence?
- Who is responsible for the product and reachable if something is wrong?
The strongest label is not the one with the most gold foil, badges, or scientific-sounding words. It is the one whose identity, quantity, serving math, ingredient list, lot number, COA, warnings, online listing, and jurisdictional review all point to the same product.
That is what product transparency looks like before any marketing begins.
Primary and authoritative sources
- FDA and Kratom
- FDA Food Labeling Guide
- 21 CFR Part 101 — Food Labeling
- 21 CFR §101.3 — Identity labeling
- 21 CFR §101.4 — Ingredient designation
- 21 CFR §101.5 — Responsible business
- 21 CFR §101.7 — Net quantity
- 21 CFR §101.36 — Dietary-supplement nutrition labeling
- 21 CFR §111.3 — Lot-number definition
- 21 CFR §111.70 — Product, packaging, and label specifications
- 21 CFR §111.415 — Packaging and labeling controls
- FDA Small Entity Compliance Guide for dietary-supplement CGMP
- FDA 7-OH warning-letter announcement
- FDA consumer information on 7-OH
- Georgia H.B. 181, Act 546
- New York Public Health Law §1399-xx
- DEA July 6, 2026 7-OH notice of intent
- HHS August 26, 2026 comment extension
- DEA August 26, 2026 MP/MGM-15/MGM-16 order
- DOJ August 25, 2026 enforcement statement
